Case Study #1: Newly Diagnosed Multiple Myeloma, Diagnostic Criteria, Response, Extended Treatment Team, Shared Decision Making, Minimal Residual Disease

Joseph D. Tariman, PhD, ANP-BC
Beth Faiman, PhD , MSN, APRN-BC, AOCN®

download slides

 

Previous Post
NLB 2016: Case #2, 3 Bone Health, Renal Health, 1+Prior Therapies, Immunotherapy, Clonal Evolution
Next Post
Robin Tuohy's testimony at CEPAC on Treatment Options for Relapsed and Refractory Myeloma.

Give Where Most Needed

We use cookies on our website to support technical features that enhance your user experience.

We also use analytics & advertising services. To opt-out click for more information.